DEMAND FOR DIGNICAP® IS STRONG AS DIGNITANA BRINGS FDA-CLEARED MEDICAL SCALP COOLING DEVICE TO MORE U.S. CANCER CENTERS

Lund, Sweden—June 10, 2016—Dignitana AB, a world leader in medical scalp-cooling
technology, announced today that the DigniCap® scalp cooling system, which was
recently cleared by the FDA to effectively reduce the likelihood of chemotherapy
-induced hair loss in women with breast cancer, is now or will soon be available
at 26 cancer treatment centers across the U.S.

The DigniCap® scalp cooling system is the first and only scalp cooling device to
complete rigorous FDA clinical trials in the U.S., where seven out of ten
patients with early-stage breast cancer kept at least 50% of their hair.

Following FDA Clearance in December 2015, medical centers across the country
have begun offering the DigniCap scalp cooling system as part of the
comprehensive cancer care treatment services they provide. Through funding from
a recent Private Placement and Rights Offering, Dignitana is rapidly expanding
its reach across America as demand for the medical device accelerates.
Agreements with 26 centers have now been signed*, with some of the early
adopters ordering additional units within months of initial set up.

To date, Dignitana has announced installations of the DigniCap® scalp cooling
system at the following U.S. medical centers: Bronson Battle Creek Cancer Care
Center (https://www.bronsonhealth.com/locations/bronson-battle-creek-cancer-care
-center/), Charleston Hematology Oncology Associates (https://www.choasc.com/),
Chesapeake Oncology and Hematology Associates (http://cohamed.org/), Florida
Cancer Specialists & Research Institute (https://www.flcancer.com/), Menorah
Medical Center (http://menorahmedicalcenter.com/service/cancer-care), Mount
Sinai Beth Israel Cancer Center (https://www.wehealny.org/services/cancer/),
Mount Sinai Comprehensive Cancer Center (http://msccc.com/), Oncology &
Hematology Specialists (http://www.oncologyandhematology.net/), Orange County
Blood and Cancer Care (http://www.memorialcare.org/), The Dubin Breast Center at
The Mount Sinai Hospital (https://www.mountsinai.org/patient-care/service
-areas/cancer/cancer-services/dubin-breast-center), Toledo Clinic Cancer
Center (http://www.toledocliniccancercenters.com/), Stamford Health Bennett
Cancer Center (https://www.stamfordhealth.org/care-treatment/cancer/cancers-we
-treat/?gclid=CjwKEAjwgPe4BRCB66GG8PO69QkSJAC4EhHhbAjPU25khADPseaFC9eNQu0U9AFQ9V
Z 
EJSM0pbvejBoC2Pjw_wcB), UCSF Helen Diller Family Comprehensive Cancer
Center (http://cancer.ucsf.edu/), UT Health Science Center San Antonio’s Cancer
Therapy & Research Center (http://www.uthscsa.edu/patient-care/ctrc), and Wake
Forest Baptist Medical Center (http://www.wakehealth.edu/).

The following cancer treatment centers are the most recent U.S. sites to include
the DigniCap® scalp cooling system as part of their breast cancer treatment care
services:

  · Hematology Oncology Consultants, a Division of Michigan Healthcare
Professionals
 (http://mhpdoctor.com/)Royal Oak, Michigan
  · UCHealth’s University of Colorado
Hospital (https://www.uchealth.org/metrodenver/Pages/default.aspx) and
University of Colorado Cancer Center
 (http://www.ucdenver.edu/academics/colleges/medicalschool/centers/cancercenter/
P 
ages/CancerCenter.aspx)Aurora, Colorado
  · UCHealth Lone Tree Health Center
 (https://www.uchealth.org/Pages/OHAM/OrgUnitDetails.aspx?OrganizationalUnitId=1
6 
5)Lone Tree, Colorado
  · The C. Anthony and Jean Whittingham Cancer Center at Norwalk
Hospital (http://www.norwalkhospital.org/departments/breast-cancer-program-at
-norwalk-hospital)
Norwalk, Connecticut
  · Weill Cornell Medicine (http://weill.cornell.edu/) and NewYork-Presbyterian
 (http://www.nyp.org/)New York, New York
  · The START Center for Cancer Care
 (http://thestartcenter.com/)San Antonio, Texas

“We are very excited that DigniCap® is being so well-received in the U.S., and
that we’ve been able to quickly and effectively fulfil product requests,” said
Jan Richardsson, Chief Executive Officer of Dignitana. “From the New York
Metropolitan area to communities throughout the midwest, the south, and
California, it is clear that DigniCap is filling an important need in quality of
life cancer care and medical centers are eagerly
promoting (http://abc7ny.com/health/medical-marvels-scalp-cooling-system
-prevents-hair-loss-from-chemotherapy/1364117/) its addition to their cancer
services.”

The DigniCap® scalp cooling system features a patented tight-fitting silicone
cooling cap that is placed directly on the head, and an outer neoprene cap that
insulates and secures the silicone cap. The cooling cap is connected to a
cooling and control unit with touch screen prompts. A liquid coolant circulates
throughout the silicone cap, delivering consistent and controlled cooling to all
areas of the scalp. The cap is fitted to the head, and the temperature of the
scalp is lowered, resulting in vasoconstriction with reduced delivery of
chemotherapy to the scalp, as well as reduced cellular uptake of drugs due to
decreased intra follicular metabolic rate. These factors together reduce the
risk of chemotherapy-induced hair loss.
För mer info:

Jan Richardsson
VD, Dignitana AB (publ)

Telefon: 046-16 30 92
E-post: jan.richardsson@dignitana.se
Om Dignitana AB (publ)
Dignitanas, med säte i Lund, affärsidé är att utveckla, tillverka och
marknadsföra den medicintekniska produkten DigniCap®. Dignitana bedriver en
kontinuerlig forskning och utveckling av nya användningsområden för DigniCap®.
Dignitanas aktier handlas på NASDAQ OMX First North med Erik Penser Bank som
Certified Adviser. För mer information gå in på: www.dignitana.se

Om skalpkylningssystemet DigniCap®
Dignitanas huvudprodukt - skalpkylningssystemet DigniCap® - är ett patenterat
system med syfte att eliminera eller kraftigt reducera håravfall för patienter
som genomgår cytostatikabehandling. DigniCap® erbjuder skalpkylning med jämn
kyla, hög effektivitet, säkerhet och acceptabel komfort.